Today, 85 years after its foundation, Corporación Farmacéutica Recalcine is the leading company in the pharmaceutical market in Chile. It is constantly developing biotechnology projects and clinical studies, supported by the main forming entities in Chile and abroad.
Corporación Farmacéutica Recalcine inaugurated in September 2006 the CFR Pharmafuturo Pharmaceutical Complex, with the purpose to become the first Latin American laboratory with a global presence and research of its own. CFR Pharmafuturo Pharmaceutical Complex was designed according to the GMP (Good Manufacturing Practice)
Govt plans to limit Pacific bluefin tuna catch Japan
The Japanese Government intends to reduce the catch of immature Pacific bluefin tuna and prevent overfishing of the high-priced fish by implementing common regulations internationally, out of criteria currently adopted independently by Japan.